Numinus to Host Q2 2023 Results Conference Call on April 13, 2023 Post published:March 30, 2023 Post category:Press Release
Numinus Launches the Practitioner Certification Pathway – a Complete Psychedelic-Assisted Therapy Training Program Post published:March 27, 2023 Post category:Press Release
Numinus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023 Post published:March 22, 2023 Post category:Press Release
Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023 Post published:March 21, 2023 Post category:Press Release
Numinus Wellness Inc. Executives to Present on Panel at Upcoming South by Southwest Conference Post published:March 7, 2023 Post category:Press Release
Numinus to Participate in a Water Tower Research Fireside Chat on Tuesday, February 28, 2023 Post published:February 24, 2023 Post category:Press Release
Numinus Expands Research Capabilities with new Phoenix Clinical Research Site Post published:February 17, 2023 Post category:Press Release
Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders Post published:February 16, 2023 Post category:Press Release
Numinus Receives Clinical Trial Application Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis Tea Post published:February 1, 2023 Post category:Press Release
Numinus Wellness Inc. Reports Q1 2023 Results Post published:January 19, 2023 Post category:Press Release